This post is unavailable.
Join now Sign in
More Relevant Posts
-
1,466 followers
- Report this post
Celebrating 25 Years of Service!AVS is excited to announce that today marks our 25th Anniversary! Providing innovative Engineering, Automation, Validation, and Clinical solutions to the pharmaceutical, biotech, medical device, and diagnostic industries.We are beyond thankful to our employees and clients for helping us make this company what it is today. AVS has come a long way from starting with the three Founders (Gladis Hwang, Mounir Azar, and Partha Mukherjee) to our many employees across the US and merging with Altura in 2022.The future is bright here at AVS, and we can't wait for many more years to come. AVS History/BackgroundOn June 15th, 1998, the AVS founders (Gladis Hwang, Mounir Azar & Partha Mukherjee) officially registered AVS, Inc in the commonwealth of PA and soon thereafter began to execute Bio-Pharma projects in PA and NJ personally. Prior to that, the partners worked well together as key managers at an Architecture & Engineering firm, Life Sciences Int’l (LSI), located in downtown Phila. In 1997-98, LSI began to decline, and business was slow, especially in Process Engineering. LSI began to lose key staff. With no sign of recovery, the three partners agreed to resign and establish our own consultancy. AVS' focus was on Automation & Validation. Soon thereafter, we added more services and developed a good headcount of engineers and scientists. AVS began engaging in international engineering & validation projects with great success. In May 2022, AVS Inc became AVS LLC after merging with Altura Healthcare, whose focus is to streamline the service offerings and to expand our footprint, mainly in the Biopharma & Medical Device sectors.#25thanniversary #validation #automation #medicaldevices #engineeringsolutions #pharmaindustry #biotechindustry #lifesciences
19
4 Comments
Like CommentTo view or add a comment, sign in
-
Robin Roberts
- Report this post
"Back To The Lab"Some of you have noticed that I have been unusually quiet on LI over the last few weeks.Well…You’re right, and there is a good reason… My passion has been my work, even before I became a molecular biologist.I have always strived to do what I love, and to do it at the highest level.Whether that was collegiate baseball, the military, or the sciences.I believe that “where focus goes, your energy flows”, and for that reason, I have always remained more than motivated, I have remained disciplined. Disciplined in making sure that I was doing what I loved, with people I cared about, supporting a mission I believed in.That was true when I founded the Global Trial Budget Management team and it was true when I co-founded the Novartis Biome. Having come from meager beginnings on a small Caribbean island, I found myself constantly asking if I could really succeed at any of this…and each day I convinced myself that “I’ll learn”, because having nothing, is everything I need to succeed.Now, the Novartis Biome is in a new stage of evolution.It has grown from a mere idea, to an efficient system of over a dozen Biome Hubs across the globe that has had real impact across the healthcare ecosystem, and in countless patient lives. However, this means I too must once again evolve, find focus and rediscover my passion and next step.I have found myself walking comfortably, when I was built to run towards my goals.It is time for me to go “back to the lab” and create yet another…better…refocused…and committed version of myself that is prepared to step into the shoes I was meant to wear.Where will this evolution take me?...I do not know.But what I do know, is that no matter where, I will once again be ready and willing to jump…and grow wings on the way down. Until then, stay tuned, be safe, and enjoy your summer…See you at takeoff! #refocus #seeitdoit #takeaction
153
73 Comments
Like CommentTo view or add a comment, sign in
-
MZF4 Medical
2,792 followers
- Report this post
Ms. Nathalia Mota (our Inside Sales Analyst) at another weekly team meeting about product development for prototyping in sports medicine. An effective way to unite different skills of each professional, which makes Mazzaferro Medical an extension lab for our clients to continuously reach high levels of innovation.Mazzaferro Medical: a MZF4 business unit.#productdevelopment #prototyping #sportsmedicine #team #innovation
51
Like CommentTo view or add a comment, sign in
-
MSCA SE CardioSCOPE
677 followers
- Report this post
Start of another secondment from Institute of Cellular Biology and Pathology "Nicolae Simionescu" to Biosfer Teslab as a part of #CardioSCOPE project. #Intersectoral collaborations promote #entrepreneurship and inspire academic researchers to explore commercial potential of their scientific achievements.
1
Like CommentTo view or add a comment, sign in
-
Ana Vilelas
Healthcare Account Manager | Positive Team Leading Culture | Biomedical Scientist | People First = success philosophy | Business Development and Growth
- Report this post
♻️🌿𝓢𝓾𝓼𝓽𝓪𝓲𝓷𝓪𝓫𝓲𝓵𝓲𝓽𝔂 𝓪𝓷𝓭 𝓝𝓮𝓽 0 🌿♻️Let’s think “𝓖𝓻𝓮𝓮𝓷𝓮𝓻” 🟢, shall we⁉️.But bear with me- I’m not going to write about 🌿🌲☘️- it’s the BIGGER/WIDER picture….Somehow this was “last weeks” main topic and this week just started around it too! 🤷♀️.🟢Talking with a few different #nhs departments about the different #poct devices around, I realized that a few of them had at least 3/4/5 𝓭𝓲𝓯𝓯𝓮𝓻𝓮𝓷𝓽 𝓭𝓮𝓿𝓲𝓬𝓮𝓼 to be able to do different tests….And I get it! I totally get it- 𝓶𝓸𝓼𝓽 𝓸𝓯 𝓽𝓱𝓮 𝓽𝓲𝓶𝓮𝓼 it’s just needed! There’s no other way (bear with me, I promise it will make a bit more sense in the end... 😉).♻️ So now, from a #sustainabilty point of view, think with me- these same 3/4/5 𝓭𝓲𝓯𝓯𝓮𝓻𝓮𝓷𝓽 𝓭𝓮𝓿𝓲𝓬𝓮𝓼 require:✅ 3/4/5 different suppliers;✅ 3/4/5 different deliveries ➡️ which equals to 3/4/5 different vans on the road 🚘;✅ 3/4/5 different testing ways, training requirements, reagents, etc etc etc….But 𝔀𝓱𝓪𝓽 𝓲𝓯 𝓘 𝓽𝓮𝓵𝓵 𝔂𝓸𝓾 that with our Dri-Chem (NX600/NX700) devices you can have #liver function, #bone function, CRP, calcium, #renal function, Magnesium, Creatinine, #glucose, #cholesterol, and plenty others all out of the same device⁉️😃 (Not forgetting the reliability and reproducibility of the results, of course!).Is this not thinking ♻️🟢⁉️.Not to mention the 𝓱𝓾𝓰𝓮 𝓬𝓸𝓶𝓶𝓲𝓽𝓶𝓮𝓷𝓽 that Fujifilm Healthcare UK, Fujifilm Europe , Fujifilm UK has to Sustainability! (📸 is just me yesterday after completing my 𝓖𝓻𝓮𝓮𝓷 𝓐𝓬𝓽 Training- All about Fujifilm’s Sustainability Commitment!).Would be interesting to hear your thoughts⁉️.#sustainability #sustainabilitymatters #thinkgreen 🟢 #fujifilmhealthcare #fujifilm #outsidethebox #sustainabilitybigpicture #ivd #fujifilmivd #drichem#bloodtests #bloodtesting #environmentalsustainabilityBritish In Vitro Diagnostics Association (BIVDA) NHS England European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
15
2 Comments
Like CommentTo view or add a comment, sign in
-
Maximilian Müller
CEO bei Moticon
- Report this post
I take a chance to write a rare own message, dedicated to our people who work for Moticon AG. 2023 has both been extraordinary exciting, but also super challenging. We are back on the scene to rumble the last quarter after a few weeks of work behind the scenes, tying new bonds and taking a breath or two. I dare giving credits for some of the most outstanding topics of the year:We have initiated a state co-funded research project on normative data for screening tests in performance sports, generated with #rego #sensorinsole and with close to 300 elite athletes been tested so far in Germany, Sweden, Austria and the U.S. - which will help trainers to make their athletes better and keep them away from injuries (https://lnkd.in/e8ZAJniS).We’ve been onboarded as the #wearabletechnology lead in whopping three major clinical projects aiming at new #digitalbiomarker, our second business cornerstone. One of them, with Novartis, counts 23 clinical sites in 8 nations. The other one, with Regeneron, includes the first ever #rego patient home testing protocol. The third, with Celestra Health Systems, is for enhancing Multiple Sclerosis patients’ care and a masterpiece in integration speed using our #sensorinsole #insole3 (https://lnkd.in/exmvS5Ph).Not to mention a new FDA project who have chosen Moticon as a representative #wearabletechnology for a new gait database (https://lnkd.in/eNU4PZCq).This is besides the daily business: sourcing, production, logistics and customer service for a growing user and partner base in Asia-Pacific, such as Galore Systems, and, most of all, in the U.S. - with outstanding customers such as Stanford University School of Medicine, Rush University Medical Center, University of Southern California and so many others.I sometimes wonder how we manage to do all that with such a small number of people. The clue is: hands on mentality, super professional, dedicated, operational excellence. So many thanks to all folks in our core team: Tanja Hein (pharma projects, ReGo specialist), Alena Minchenia (accounting & logistics), Malgorzata Zygula (production), Melanie Priewasser (communications), Florian Zierer (software lead), Robert Vilzmann (algorithms & brain), Florian Braunmiller (sports science, data analyst), Manuel Perez Prada and Thor Unbescheid (design), Christopher Popfinger (erp & database), Frederic Rothe (customer quality manager), Raphael Ziegler (PT specialist), Ulrich Seidel (advisory board), Andre Zschernig (board member).Moticon is glad to be so close to some of the most beautiful places in Germany, the 5 lakes area south of Munich, and we make sure that once in a while we give back a bit of time to relax and have fun with a swim and a BBQ. Thanks to Markus Mooser (advisory board) for the place!!!
64
10 Comments
Like CommentTo view or add a comment, sign in
-
- Report this post
“Culture eats strategy for breakfast” (Peter Drucker) 💡 With this motto, in March 2023, all employees of Daiichi Sankyo (Schweiz) AG) engaged in a co-creation effort to build our joint mission, vision and core behaviors.This journey was fascinating! It was filled with fruitful exchanges, passionate debates, commitment to get to a result that would have captured our hearts and stimulated our minds.As for every global company, mission, vision and core behaviors are harmonized at global level. Hence, a part of the journey was aimed at addressing the following key question: How do we build on our global legacy and add the local twist to make sure we can perceive our corporate culture as fully ours?We believe in a culture of collaboration, respect and support. Every member of our team is valuable and contributes to the success of the company. By aligning ourselves with these values, we strive to grow together as a team and move our company forward to make a positive impact. This is true in Daiichi Sankyo, regardless of which country we operate.Images might be the best way to express a concept and memorize it, hence, together with a very talented visual artist helge windisch, we have decorated our office to show an image of how our global behaviors meet with the Swiss mountaineering and adventurous spirit which animates all of us!#DaiichiSankyo #Teamwork #Wecareforeveryheartbeat #Companyvalues #Cardiology #Oncology #Companyculture #Teamwork #Wallprint #Companymission #Companyvision #Pharma
67
Like CommentTo view or add a comment, sign in
-
Market Unwinded
1,171 followers
- Report this post
Nevro's Acquisition of Vyrsa Technologies: A Masterstroke in Medical Device Market Expansion marketunwinded.com#HealthTechMergers: Nevro's Acquisition of Vyrsa Technologies Elevates the Medical Device ArenaThe $75 million-dollar acquisition of VYRSA™ Technologies by Nevro is a strategic coup that's set to revolutionize patient care in the treatment of chronic low back pain - a condition plaguing up to 30% of the population globally.Why It's a Game Changer: 👨⚕️ Diversification: Nevro's investment extends its portfolio into FDA-approved SI joint fusion technologies, tapping into a wider medical need and patient demographic. 👨⚕️ Precision Care: Aligning with the industry’s lean towards tailored patient treatment, Nevro capitalizes on Vyrsa’s adaptability in providing precision solutions. 👨⚕️ Payer Acceptance: Embracing Vyrsa's devices, which utilize Category I CPT codes, may increase physician adoption and patient access to groundbreaking treatments.Market Implications: 💡 Accelerated Competitor Response: Rivals are prompted to revisit their offerings, fostering a catalyst for increased medical device innovation. 💡 Potentially Revised Clinical Protocols: With more therapeutic options, healthcare providers are likely to adapt care steps, improving patient outcomes.Investment Insights: $ The merger indicates Nevro's potential for enhanced market penetration and visibility — making it a magnet for growth-minded investors. $ Innovation lies at its core, spotlighting Nevro as a company that both investors and competitors should watch for pioneering R&D initiatives. $ Strategic synergies from this acquisition may yield cost efficiencies and augmented returns, enhancing long-term investor trust.Nevro's move is not merely about expansion; it’s a statement of intent to lead the pack in health tech innovation. For investors and industry players, this is the bellwether of an era where strategic mergers shape the trajectory of patient care and clinical improvement. Read More: https://lnkd.in/gB-_YkHE#HealthTech #Nevro #VyrsaTechnologies #MedicalDevices #StrategicAcquisition #PatientCareInnovation
163
Like CommentTo view or add a comment, sign in
-
Kathrin Brenker
CEO and Co-founder at opto biolabs -- Illumination devices for optogenetics, photopharmacology and more! -- MIT - Innovator under 35 Europe -- TEDx speaker
- Report this post
Meet Emilija Bostogaite!She is not just a real engineering superstar with superior patience but also known for her meticulous attention to detail.What's even more exciting? She's knee-deep in research for our upcoming white paper, diving deep into the absorption properties of various cell culture well plates. 🧪🔬 The results promise to be enlightening, so stay tuned for the big reveal!#teamspirit #teamiseverything #biophotonics
37
Like CommentTo view or add a comment, sign in
-
1,802 followers
- 32 Posts
View Profile
FollowExplore topics
- Sales
- Marketing
- Business Administration
- HR Management
- Content Management
- Engineering
- Soft Skills
- See All
